HANGZHOU, China, Aug. 25, 2022 /PRNewswire/ — Hangzhou Tigermed Consulting Co., Ltd. (“Tigermed” or the “company”) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its interim results for the first half of 2022, ended June 30, […]
Reports
Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 15, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, […]
The Parent Company Reports Second Quarter 2022 Financial Results
Reports net sales of $27.4 million as the Company focuses on higher quality revenue streams Increases omni-channel retail revenue 60% from prior year to $19 million, or 69% of net sales in the quarter Sales of Company-owned brands increased to an average of 29% of products sold through its retail […]